Delivers high-performance host-cell products and PicoShell screening technology for biomanufacturing and biotech companies, increasing titers, enabling alternative feedstocks, and lowering downstream processing costs. Provides contract strain-engineering and cell-line development services that compress engineering timelines from years to months with no revenue sharing or back-end royalties.